In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetes

Medicine & Life Sciences

• ZP3022 100%
• gastrin 17 19%
• In Vitro Techniques 18%
• Exenatide 17%
• Insulin Secretion 16%
• Glucose 10%
• Apoptosis 7%
• Therapeutics 6%
• Islet Amyloid Polypeptide 5%
• Amyloidogenic Proteins 5%
• Cell Proliferation 5%
• Palmitates 5%
• Endocrine Cells 5%
• Gene Expression 4%
• Glucagon-Like Peptide 1 4%
• Gastrins 4%
• Gene Expression Profiling 4%
• Microarray Analysis 4%
• Islets of Langerhans 4%
• Pancreas 3%
• Cytokines 2%
• Genes 1%
• Proteins 1%